Management of functional bowel disorders: double-blind evaluation of Cantil and Cantate.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001561:Benzilates / Q000627:therapeutic use*; D001965:Bromides; D002986:Clinical Trials as Topic; D003108:Colonic Diseases / Q000188:drug therapy*; D003967:Diarrhea / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D008620:Meprobamate / Q000627:therapeutic use; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*
D001561:Benzilates; D001965:Bromides; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; D008620:Meprobamate